Healthcare -
Biotechnology - NASDAQ - US
$ 3.69
2.5 %
$ 39.8 M
Market Cap
-2.07
P/E
LTRN - LONG-TERM DEBT
Long-term Debt LTRN - Lantern Pharma Inc.
61.5 K
LAST VALUE
7.83%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR